CPHI vs CTAS · rev $4.1M vs P/E 51, rev $10.34B
China Pharma Holdings Inc (CPHI) versus Cintas Corporation (CTAS) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported CTAS revenue for 2025-05-31 was $10.34B. Net income was $1.81B. Revenue was up 7.7% from 2024-05-31 to 2025-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
CPHI currently screens at market cap $29.0M. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Not investment advice. Open the CPHI and CTAS stock pages for the full models.
Not investment advice.